Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial (vol 180, pg 1345, 2020)

被引:0
|
作者
Hermine, O.
Mariette, X.
Tharaux, P-L
Resche-Rigon, M.
Porcher, R.
Ravaud, p
机构
关键词
D O I
10.1001/jamainternmed.2021.3845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1021 / 1021
页数:1
相关论文
共 50 条
  • [31] A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
    Louise Thorlacius-Ussing
    Patrick Terrence Brooks
    Henrik Nielsen
    Bitten Aagaard Jensen
    Lothar Wiese
    Susanne Gjørup Sækmose
    Stine Johnsen
    Mikkel Gybel-Brask
    Isik S. Johansen
    Mie Topholm Bruun
    Nina Breinholdt Stærke
    Lars Østergaard
    Christian Erikstrup
    Sisse Rye Ostrowski
    Keld Mikkelsen Homburg
    Jørgen Georgsen
    Susan Mikkelsen
    Håkon Sandholdt
    Cæcilie Leding
    Nichlas Hovmand
    Clara Lundetoft Clausen
    Michaela Tinggaard
    Karen Brorup Heje Pedersen
    Katrine Kjær Iversen
    Sandra Tingsgård
    Simone Bastrup Israelsen
    Thomas Benfield
    Scientific Reports, 12
  • [32] A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
    Thorlacius-Ussing, Louise
    Brooks, Patrick Terrence
    Nielsen, Henrik
    Jensen, Bitten Aagaard
    Wiese, Lothar
    Saekmose, Susanne Gjorup
    Johnsen, Stine
    Gybel-Brask, Mikkel
    Johansen, Isik S.
    Bruun, Mie Topholm
    Staerke, Nina Breinholdt
    Ostergaard, Lars
    Erikstrup, Christian
    Ostrowski, Sisse Rye
    Homburg, Keld Mikkelsen
    Georgsen, Jorgen
    Mikkelsen, Susan
    Sandholdt, Hakon
    Leding, Caecilie
    Hovmand, Nichlas
    Clausen, Clara Lundetoft
    Tinggaard, Michaela
    Pedersen, Karen Brorup Heje
    Iversen, Katrine Kjaer
    Tingsgard, Sandra
    Israelsen, Simone Bastrup
    Benfield, Thomas
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] Methylprednisolone in adults hospitalized with COVID-19 pneumonia An open-label randomized trial (GLUCOCOVID)
    Corral-Gudino, Luis
    Bahamonde, Alberto
    Arnaiz-Revillas, Francisco
    Gomez-Barquero, Julia
    Abadia-Otero, Jesica
    Garcia-Ibarbia, Carmen
    Mora, Victor
    Cerezo-Hernandez, Ana
    Hernandez, Jose L.
    Lopez-Muniz, Graciela
    Hernandez-Blanco, Fernando
    Cifrian, Jose M.
    Olmos, Jose M.
    Carrascosa, Miguel
    Nieto, Luis
    Farinas, Maria Carmen
    Riancho, Jose A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (7-8) : 303 - 311
  • [34] Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial
    Garcia-Vicuna, Rosario
    Rodriguez-Garcia, Sebastian C.
    Abad-Santos, Francisco
    Hernandez, Azucena Bautista
    Garcia-Fraile, Lucio
    Blandino, Ana Barrios
    Liarte, Angela Gutierrez
    Alonso-Perez, Tamara
    Cardenoso, Laura
    Alfranca, Aranzazu
    Mejia-Abril, Gina
    Sanz, Jesus Sanz
    Gonzalez-Alvaro, Isidoro
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial
    Caricchio, Roberto
    Abbate, Antonio
    Gordeev, Ivan
    Meng, Jamie
    Hsue, Priscilla Y.
    Neogi, Tuhina
    Arduino, Roberto
    Fomina, Daria
    Bogdanov, Roman
    Stepanenko, Tatiana
    Ruiz-Seco, Pilar
    Gonzalez-Garcia, Andres
    Chen, Yu
    Li, Yuhan
    Whelan, Sarah
    Noviello, Stephanie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (03): : 230 - 239
  • [36] The Clinical Effects of Laser Acupuncture on Hospitalized Patients With Severe COVID-19: A Randomized Clinical Trial
    Shojaeddin, Arista
    Fatemi, Alireza
    Razzaghi, Zahra
    Pishgahi, Mehdi
    Sherafat, Somayeh Jahani
    Razzaghi, Mohammadreza
    Shahrzad, Mohamad Karim
    Anaraki, Nafiseh
    Salehi, Chiman
    Amiri, Aslan
    JOURNAL OF LASERS IN MEDICAL SCIENCES, 2023, 14
  • [37] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 328, pg 1595, 2022)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (02): : 178 - 178
  • [38] Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)
    Mccarthy, M. W.
    Naggie, S.
    Boulware, D. R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (16): : 1589 - 1589
  • [39] Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
    Mariette, Xavier
    Hermine, Olivier
    Tharaux, Pierre Louis
    Resche-Rigon, Matthieu
    Porcher, Raphael
    Ravaud, Philippe
    Bureau, Serge
    Dougados, Maxime
    Tibi, Annick
    LANCET RESPIRATORY MEDICINE, 2021, 9 (03): : 295 - 304
  • [40] Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
    Charles Bruen
    Mukhtar Al-Saadi
    Edward A. Michelson
    Maged Tanios
    Raul Mendoza-Ayala
    Joseph Miller
    Jeffrey Zhang
    Kenneth Stauderman
    Sudarshan Hebbar
    Peter C. Hou
    Critical Care, 26